Cart
sales@molnova.com
Benzylideneaniline
CAS No. 538-51-2
Benzylideneaniline( N-Benzylideneaniline )
Catalog No. M27245 CAS No. 538-51-2
Benzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzylideneaniline
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
-
DescriptionBenzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
-
In Vitro——
-
In Vivo——
-
SynonymsN-Benzylideneaniline
-
PathwayOthers
-
TargetOther Targets
-
RecptorSR-BI
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number538-51-2
-
Formula Weight181.238
-
Molecular FormulaC13H11N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=N/c1ccccc1)\c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nieland TJ, Shaw JT, Jaipuri FA, Maliga Z, Duffner JL, Koehler AN, Krieger M. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. J Lipid Res. 2007 Aug;48(8):1832-45. Epub 2007 May 28. PubMed PMID: 17533223.
molnova catalog
related products
-
Leptin (22-56), huma...
Leptin(22-56),human is a peptide fragment of Leptin, which ACTS through a variety of subtypes of Ob-Rs.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
-
11-Maleimidoundecano...
11-Maleimidoundecanoic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
